Advanced Cell Technology's Dr. Robert Lanza Will Be a Featured Speaker at the 6th Annual Stem Cells & Regenerative Medicine Meeting.ALAMEDA, Calif. -- Advanced Cell Technology, Inc.'s (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :ACTC ACTC Apple Certified Technical Coordinator ACTC Almaden Cycle Touring Club ACTC Associated Colleges of the Twin Cities ACTC All Ceylon Tamil Congress (Sri Lanka) ACTC Association Canadienne de Télévision par Câble ) Robert Lanza, M.D., Vice President of Research & Scientific Development, will speak on "Human ESC-Derived Cells for Rescue of Visual Function and Repair of Vascular Damage," at the 6th Annual Stem Cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young & Regenerative Medicine meeting October 16-17, 2006 at the Renaissance Pittsburgh Hotel in Pittsburgh, PA. Dr. Lanza will present on Monday, October 16th at 9:30 a.m. and such presentation shall be available on the company's website. Embryonic stem cells promise to provide a well-characterized and reproducible source of replacement tissue for human clinical studies. Two early potential applications of this technology are the use of human embryonic stem cell (hESC)-derived retinal pigment epithelium The retinal pigment epithelium (RPE) is the pigmented cell layer just outside the neurosensory retina that nourishes retinal visual cells, and is firmly attached to the underlying choroid and overlying retinal visual cells. (RPE RPE Retinal Pigment Epithelium RPE Rating of Perceived Exertion (exercise) RPE Respiratory Protective Equipment RPE Regular Pulse Excitation RPE Registered Professional Engineer RPE Rapid Palatal Expansion ) for the treatment of retinal degenerative diseases such as macular degeneration macular degeneration, eye disorder causing loss of central vision. The affected area, the macula, lies at the back of the retina and is the part that produces the sharpest vision. and retinitis pigmentosa Retinitis Pigmentosa Definition Retinitis pigmentosa (RP) refers to a group of inherited disorders that slowly lead to blindness due to abnormalities of the photoreceptors (primarily the rods) in the retina. , and the use of hESC-derived hemangioblasts for vascular restoration of organs and limbs. Recent progress using these cells to affect substantial functional and morphological rescue in animals will be discussed. About Advanced Cell Technology, Inc. Advanced Cell Technology, Inc. is a biotechnology company applying stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information about the company, please visit http://www.advancedcell.com. Forward-Looking Statements Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended June 30, 2006. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion